Pharmaceutical solutions & Specialty ingredients

About SEQENS group

Our main activities

A leader in
Pharmaceutical synthesis

Discover

A strong expertise in
Specialty Ingredients

Discover

A complete and integrated
R&D offer

Discover

Committed to developing
and sustainably producing

Discover

Newsroom

#Live

General

White Paper on Aspirin: 1st result of the Technology cooperation between SEQENS and RONDOL announced in March.

AcetylSalicylic Acid (ASA better known as Aspirin) is one of the most popular Non-Steroidal Anti-Inflammatory Drugs (NSAID) in the world. First used…
Read more See all news
General / Press Release

Professor Patrick Couvreur joins the Scientific Council of Seqens led by Professor Bernard Meunier, Former President of the French Académie des Sciences.

Professor Patrick Couvreur, Emeritus Professor of Pharmacy at Paris-Saclay University, has a world-renowned expertise in the design of new nanomedicines for the treatment…
Read more See all news
General

Raymond Sinnah's interview in 2021 Singapore Chemicals edition

Singaporean chemical industry Global Business Reports (GBR) launches its 2021 Singapore Chemicals edition in a digital interactive format. This report describes the performance of…
Read more See all news

#Jobs

See all our offers

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries